Privacy preference

MEDtalks would like to keep you informed about the content that is most relevant to you. Click here for more information.

​ASCO GU 2017: Durvalumab in advanced UCC

A selection of posters from the 2017 Genitourinary Cancers Symposium is highlighted in a series of interviews.

Speaker: Thomas Powles

Poster: B286 - Updated efficacy and tolerability of durvalumab in locally advanced or metastatic urothelial carcinoma.

  • Sponsors

    This program is editorially independent and is financially supported by:

Related items